Trimester-specific phthalate exposures in pregnancy are associated with circulating metabolites in children

Jaclyn M Goodrich1, Lu Tang2, Yanelli R Carmona3

  • 1Department of Environmental Health Sciences, University of Michigan School of Public Health, Ann Arbor, MI, United States of America.

Plos One
|August 30, 2022
PubMed

Insights

Prenatal phthalate exposure impacts child metabolism, with effects varying by sex and timing of exposure during pregnancy. Metabolomics reveals these subtle changes before clinical signs of cardiometabolic risk appear.

Area of Science:

  • Environmental Health
  • Metabolomics
  • Pediatric Endocrinology

Background:

  • Prenatal exposure to phthalates is linked to sex-specific adiposity in peripubertal children.
  • Untargeted metabolomics can identify biochemical pathways affected by early-life exposures.
  • Metabolomic analysis may reveal cardiometabolic risks before clinical markers are evident.

Purpose of the Study:

  • To investigate associations between prenatal phthalate exposure and serum metabolites in children.
  • To characterize sex- and gestational-timing specific metabolic alterations.
  • To identify early biomarkers of cardiometabolic risk.

Main Methods:

  • Utilized the ELEMENT birth cohort, measuring phthalate metabolites in maternal urine across trimesters.
  • Employed mass-spectrometry based untargeted metabolomics on serum from 110 boys and 124 girls (aged 8-14).
  • Analyzed associations between trimester-specific toxicants and 572 annotated metabolites, adjusting for covariates and controlling for multiple comparisons (q<0.1).

Main Results:

  • Phthalate metabolites (MEP, MiBP, MCPP) in the first trimester were linked to reduced 2-deoxy-D-glucose in all children.
  • In girls, third-trimester phthalates (MECPP, MEHHP, MEHP, MCPP) associated with altered choline, acylcarnitines, and fatty acids.
  • In boys, third-trimester MIBP related to increased saturated fatty acids, and second-trimester MBzP inversely associated with thyroxine.

Conclusions:

  • Metabolomics biomarkers can detect sex- and exposure timing-specific responses to prenatal phthalates.
  • These metabolic changes may precede standard clinical markers of cardiometabolic risk.
  • Findings highlight the utility of metabolomics in understanding early environmental influences on child health.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
1.9K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.1K
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.0K